STOCKHOLDERS’ EQUITY

6 Months Ended

Jun. 30, 2025

Equity [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 3 – STOCKHOLDERS’ EQUITY

On June 16, 2025, the Company granted stock options under the Company’s 2019 Equity Compensation Plan to a third party for services to purchase 20,000 shares at $20.00 per share. These options were exercisable immediately. The fair market value of the options at the grant date was determined to be $255,303, which was expensed in the second quarter of 2025. The options were valued using the Black Scholes option pricing model with the following assumptions: 1) a current stock price per share of $20.00, based on the price of recent offerings; 2) expected term of 5 years; 3) computed volatility of 75.10%; and 4) the risk-free rate of return of 4.04%. The exercise period of the options terminates on June 16, 2030.

In the first half of 2025, we sold 518,500 shares of our common stock for $10,370,000 in private transactions. We did not pay commissions or finder’s fees and are using the proceeds for working capital.

In the first half of 2025, we issued 60,169 shares of our common stock to unrelated third parties as compensation for their consulting services. The stock was valued at $1,203,380.

In the first half of 2024, we issued 203,650 shares of our common stock for $4,073,000 in private transactions. We did not pay commissions or finder’s fees and are using the proceeds for working capital.

In the first half of 2024, we issued 12,500 shares valued at $250,000 as a retainer pursuant to our engagement of Anglo-Chinese Financial as our investment banker.

In the first half of 2024 we issued 713 shares of our common stock to unrelated third parties as compensation for their consulting services. The stock was valued at $14,260.

In the first half of 2025 stock option expenses amounted to $1,164,408 compared to $395,624 for the same period in 2024.

As of June 30, 2025, the Company had 27,407,052 shares of common stock issued and outstanding.

The following table represents option activity for the six months ended June 30, 2025:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding - December 31, 2024		1,851,074	$	9.82		3.49
Exercisable - December 31, 2024		1,357,574	$	8.99		2.50	$	-
Granted		20,000	$	20.00
Forfeited		-
Vested				-
Outstanding – June 30, 2025		1,871,074	$	9.92		3.02
Exercisable – June 30, 2025		1,427,574	$	9.08		2.14	$	-